IOL Chemicals jumps after receiving CEP for Quetiapine Fumarate
06 - Mar - 2025 12:00 | 26 days ago
The said certification will enable the company to export Quetiapine Fumarate to European and other countries that accept CEPs. Quetiapine Fumarate is an antipsychotic drug which is widely used to treat various mental health disorders.
IOL Chemicals and Pharmaceuticals is a pharma API and speciality chemicals manufacturer.
The company’s consolidated net profit declined 11% to Rs 20.53 crore in Q3 FY25 as compared with Rs 23.08 crore in Q3 FY24. Net sales increased marginally to Rs 523.30 crore in Q3 FY25, up .0.6% as compared with Rs 520.39 crore in Q3 FY24.
Board of IOL Chemicals & Pharmaceuticals recommends interim dividend
13 - Feb - 2025 12:00 | 47 days ago
IOL Chemicals & Pharmaceuticals announced that the Board of Directors of the Company at its meeting held on 12 February 2025, inter alia, have recommended the interim dividend of Rs 4 per equity Share (i.e. 40%) , subject to the approval of the shareholders.
Board of IOL Chemicals & Pharmaceuticals recommends interim dividend
13 - Feb - 2025 12:00 | 47 days ago
IOL Chemicals & Pharmaceuticals announced that the Board of Directors of the Company at its meeting held on 12 February 2025, inter alia, have recommended the interim dividend of Rs 4 per equity Share (i.e. 40%) , subject to the approval of the shareholders.
IOL Chemicals & Pharmaceuticals consolidated net profit declines 11.05% in the December 2024 quarter
13 - Feb - 2025 12:00 | 47 days ago
Net profit of IOL Chemicals & Pharmaceuticals declined 11.05% to Rs 20.53 crore in the quarter ended December 2024 as against Rs 23.08 crore during the previous quarter ended December 2023. Sales rose 0.56% to Rs 523.30 crore in the quarter ended December 2024 as against Rs 520.39 crore during the previous quarter ended December 2023.
IOL Chemicals jumps after receiving CEP for Quetiapine Fumarate
06 - Mar - 2025 12:00 | 26 days ago
The said certification will enable the company to export Quetiapine Fumarate to European and other countries that accept CEPs. Quetiapine Fumarate is an antipsychotic drug which is widely used to treat various mental health disorders.
IOL Chemicals and Pharmaceuticals is a pharma API and speciality chemicals manufacturer.
The company’s consolidated net profit declined 11% to Rs 20.53 crore in Q3 FY25 as compared with Rs 23.08 crore in Q3 FY24. Net sales increased marginally to Rs 523.30 crore in Q3 FY25, up .0.6% as compared with Rs 520.39 crore in Q3 FY24.
Board of IOL Chemicals & Pharmaceuticals recommends interim dividend
13 - Feb - 2025 12:00 | 47 days ago
IOL Chemicals & Pharmaceuticals announced that the Board of Directors of the Company at its meeting held on 12 February 2025, inter alia, have recommended the interim dividend of Rs 4 per equity Share (i.e. 40%) , subject to the approval of the shareholders.
IOL Chemicals & Pharmaceuticals consolidated net profit declines 11.05% in the December 2024 quarter
13 - Feb - 2025 12:00 | 47 days ago
Net profit of IOL Chemicals & Pharmaceuticals declined 11.05% to Rs 20.53 crore in the quarter ended December 2024 as against Rs 23.08 crore during the previous quarter ended December 2023. Sales rose 0.56% to Rs 523.30 crore in the quarter ended December 2024 as against Rs 520.39 crore during the previous quarter ended December 2023.
IOL Chemicals jumps after receiving CEP for Quetiapine Fumarate
06 - Mar - 2025 12:00 | 26 days ago
The said certification will enable the company to export Quetiapine Fumarate to European and other countries that accept CEPs. Quetiapine Fumarate is an antipsychotic drug which is widely used to treat various mental health disorders.
IOL Chemicals and Pharmaceuticals is a pharma API and speciality chemicals manufacturer.
The company’s consolidated net profit declined 11% to Rs 20.53 crore in Q3 FY25 as compared with Rs 23.08 crore in Q3 FY24. Net sales increased marginally to Rs 523.30 crore in Q3 FY25, up .0.6% as compared with Rs 520.39 crore in Q3 FY24.
Board of IOL Chemicals & Pharmaceuticals recommends interim dividend
13 - Feb - 2025 12:00 | 47 days ago
IOL Chemicals & Pharmaceuticals announced that the Board of Directors of the Company at its meeting held on 12 February 2025, inter alia, have recommended the interim dividend of Rs 4 per equity Share (i.e. 40%) , subject to the approval of the shareholders.
Board of IOL Chemicals & Pharmaceuticals recommends interim dividend
13 - Feb - 2025 12:00 | 47 days ago
IOL Chemicals & Pharmaceuticals announced that the Board of Directors of the Company at its meeting held on 12 February 2025, inter alia, have recommended the interim dividend of Rs 4 per equity Share (i.e. 40%) , subject to the approval of the shareholders.
IOL Chemicals & Pharmaceuticals consolidated net profit declines 11.05% in the December 2024 quarter
13 - Feb - 2025 12:00 | 47 days ago
Net profit of IOL Chemicals & Pharmaceuticals declined 11.05% to Rs 20.53 crore in the quarter ended December 2024 as against Rs 23.08 crore during the previous quarter ended December 2023. Sales rose 0.56% to Rs 523.30 crore in the quarter ended December 2024 as against Rs 520.39 crore during the previous quarter ended December 2023.
